AU2018900114A0 - 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents - Google Patents

5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents

Info

Publication number
AU2018900114A0
AU2018900114A0 AU2018900114A AU2018900114A AU2018900114A0 AU 2018900114 A0 AU2018900114 A0 AU 2018900114A0 AU 2018900114 A AU2018900114 A AU 2018900114A AU 2018900114 A AU2018900114 A AU 2018900114A AU 2018900114 A0 AU2018900114 A0 AU 2018900114A0
Authority
AU
Australia
Prior art keywords
thiazol
pyrimidin
therapeutic agents
urea derivatives
urea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900114A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Australia
Original Assignee
University of South Australia
Filing date
Publication date
Application filed by University of South Australia filed Critical University of South Australia
Publication of AU2018900114A0 publication Critical patent/AU2018900114A0/en
Priority to AU2019207517A priority Critical patent/AU2019207517A1/en
Priority to CA3087805A priority patent/CA3087805A1/en
Priority to CN201980012403.9A priority patent/CN111757881B/en
Priority to EP19738966.1A priority patent/EP3740484B1/en
Priority to PCT/AU2019/000005 priority patent/WO2019136514A1/en
Priority to US16/961,986 priority patent/US11325900B2/en
Priority to JP2020538854A priority patent/JP7406808B2/en
Priority to US17/724,629 priority patent/US20230092876A1/en
Abandoned legal-status Critical Current

Links

AU2018900114A 2018-01-15 2018-01-15 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents Abandoned AU2018900114A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AU2019207517A AU2019207517A1 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
CA3087805A CA3087805A1 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
CN201980012403.9A CN111757881B (en) 2018-01-15 2019-01-14 5- (Pyrimidin-4-yl) thiazol-2-yl urea derivatives as therapeutic agents
EP19738966.1A EP3740484B1 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
PCT/AU2019/000005 WO2019136514A1 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
US16/961,986 US11325900B2 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
JP2020538854A JP7406808B2 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
US17/724,629 US20230092876A1 (en) 2018-01-15 2022-04-20 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
AU2018900114A0 true AU2018900114A0 (en) 2018-01-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP3889153A4 (en) Pyrimidine and five-membered nitrogen heterocycle derivative, preparation method therefor, and medical uses thereof
EP3331880A4 (en) N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds
HK1259623A1 (en) Pyrazolo[1,5a]pyrimidine derivatives as irak4 modulators
EP4037688A4 (en) Antiviral heterocyclic compounds
EP3816153A4 (en) Heterocyclic compound and use thereof
EP3896060A4 (en) Heterocyclic compound
HK1215430A1 (en) 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3- c]pyridine derivatives as nik inhibitors for the treatment of cancer 3-(2--4-)-5-(3-)-1h-[23-c] nik
EP3895707A4 (en) Heterocyclic compound
EP3454896A4 (en) Heterocyclic derivatives for the thratment of rsv
AU2015211852A1 (en) Heterocyclic sulfonamide derivative and medicine comprising same
EP3573583A4 (en) Active hand orthosis
EP3492468A4 (en) Heterocyclic compound as jak inhibitor, and salts and therapeutic use thereof
EP3697419A4 (en) Amine-substituted heterocyclic compounds as ehmt2 inhibitors and derivatives thereof
EP3802495A4 (en) Heterocyclic derivatives and use thereof
EP3594216A4 (en) Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharmaceutical composition and application thereof
EP3373931A4 (en) Heterocyclic compounds for the treatment of disease
EP3888652A4 (en) Heterocyclic compound
EP3781576A4 (en) Boronic acid derivatives and therapeutic uses thereof
EP3807282A4 (en) Heterocyclic derivatives and use thereof
EP3901138A4 (en) Compound for use in retinal diseases
EP3952876A4 (en) Heterocyclic compounds and uses thereof
EP3952875A4 (en) Heterocyclic compounds and uses thereof
EP3952877A4 (en) Heterocyclic compounds and uses thereof
ZA202106024B (en) Heterocyclic derivatives
EP3740484A4 (en) 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents